Back to Agenda
Session 12: Risk Assessment in Clinical Trials
Session Chair(s)
William Gregory, PHD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
- This session will address risk assessment, mathematics of drug safety, and an introduction to benefit-risk.
Have an account?